Kytopen
PrivateLast Round
Series B
Apr 7, 2026
Total Funding Raised
$44.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kytopen is a biotechnology company that provides a cell engineering platform for producing healthy and functional cells quickly and efficiently.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kytopen Comparables
Compare Kytopen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellFE | 87% | |
| Portal Biotechnologies | 87% | |
| Celetrix | 84% |
Kytopen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 7, 2026 | ||||
| Grant | Aug 13, 2024 | ||||
| Convertible Debt | Feb 14, 2024 | ||||
| Series A | Sep 28, 2021 | ||||
| Grant | Jun 16, 2021 | ||||
Grant | Jun 2, 2020 |
Kytopen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A, Series B, Seed |
| National Institute of Allergy and Infectious Diseases | Grant |
| The Engine | Series A, Series B, Pre Seed, Seed |
| Engine Ventures | Series A, Seed, Series B |
| MassVentures | Grant, Series A, Series B |
| Northpond Ventures | Series B, Series A |
| Alexandria Venture Investments | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 51% MoM.
- Apr 7, 2026
Raised Series B round.
Kytopen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kytopen's valuation, stock price, and market status.
Is Kytopen a public or private company?
Kytopen is a private company.
What is the current stock price of Kytopen?
Kytopen is a private company with no public stock price. No recent secondary market data is available.
How much is Kytopen worth (valuation)?
Valuation information for Kytopen is not publicly available.
Can I buy Kytopen stock?
Kytopen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kytopen's last funding round?
Kytopen's most recent funding round was Series B on April 7, 2026.
Who are the main investors in Kytopen?
Key investors in Kytopen include Horizons Ventures, The Engine, Northpond Ventures, Telegraph Hill Partners, Northpond Ventures.
Will Kytopen IPO soon?
No public IPO plans have been announced for Kytopen.
How can I track Kytopen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kytopen's secondary market activity and sign up for updates.